Influence
March 21, 2022

Revolutionizing research through pragmatic trials

Regenstrief Institute Research Scientist Kathleen Unroe, M.D., MHA, M.S., is at the forefront of the next generation of research methodology: pragmatic trials. Pragmatic trials are designed to evaluate the effectiveness of interventions in real-life practice, speeding up the time from discovery to implementation.  

Dr. Unroe, along with Regenstrief faculty member Susan Hickman, PhD, is leading one of few pragmatic trials funded by the National Institute on Aging. The APPROACHES (Aligning Patient Preferences – a Role Offering Alzheimer’s patients, Caregivers, and Healthcare providers Education and Support) trial is being conducted in 150 nursing homes, testing an intervention to support advance care planning.  

She is also part of the IMPACT Collaboratory, a research incubator to develop pragmatic trials and train researchers to design and execute them.  

In 2021, Dr. Unroe spoke at a conference about pragmatic trials in long-term care facilities. The event identified priorities and best practices for trials taking place in these real-world settings. 

Dr. Unroe says she is excited about the potential of pragmatic trials for creating solutions as well as creating partnerships between researchers and healthcare systems.  

In addition to being a research scientist in the IU Center for Aging Research at Regenstrief Institute, Dr. Unroe is an associate professor at the IU School of Medicine and a practicing geriatrician. 

  • Kathleen Unroe

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time